# Blank Bio

Source: https://onco.cc/companies/blank-bio/  
OnCo record `blank-bio` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Blank Bio trains AI models on tumour RNA to predict how a disease will progress and which patients will respond, so drug companies can run smarter cancer trials.

## Summary

Blank Bio is an applied AI research lab training RNA foundation models on transcriptomic data to learn patterns of disease progression and treatment response, with the aim of improving clinical trial success rates in oncology by capturing what makes each patient's tumour unique. The team comes from Recursion, Deep Genomics, DeepMind, Amazon, Memorial Sloan Kettering, Stanford and the Vector Institute. Its website describes the work as RNA intelligence for precision oncology; products are in development.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: San Francisco, CA
- Type: ai-software
- Website: https://blank.bio

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/blank-bio
- Official website: https://blank.bio

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [AI-driven drug & target discovery](https://onco.cc/technologies/ai-drug-design/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/blank-bio.json